Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema

NCT03821168 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.

NCT NCT03821168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
Lead sponsor
Shahid Beheshti University of Medical Sciences
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 1, 2019
Completion date
October 1, 2019
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory diabetic macular edema